Larvol Delta - TAK0791006-A-Study-of-Mezagitamab-in-Adults-With-Primary-Immunoglobulin-A-Nephropathy-Receiving-Stable-Background-Therapy

mezagitamab (TAK-079) - Takeda

http://clinicaltrials.gov/ct2/show/NCT05174221

Jan 27, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next